Serology Testing for COVID-19: Dr. Elitza Theel
Elitza Theel, Ph.D., Laboratory Director of the Infectious Diseases Serology Laboratory at Mayo Clinic, led the efforts to evaluate and implement the serologic antibody test for COVID-19. She gives an overview of Mayo Clinic’s COVID-19 antibody test, as w
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Full Show Notes (Timestamps)
Speaker 1: (00:56)
So there continues to be a lot of interest in antibody testing for COVID-19. Can you refresh our memories on what antibody testing is?
Speaker 1: (02:12)
Now that we are actually six months into this outbreak, what is our understanding about using serologic testing? Will it be the magic bullet that will allow us to go back to work?
Speaker 1: (05:26)
Can you explain that to everyone in ways that we could all understand? What does this mean exactly? How does this impact serologic testing and interpretation of results?
Speaker 1: (09:29)
So given this information on the positive predictive value and how it's influenced by both the prevalence and specificity of a test, have government agencies provided guidance on how to select and interpret serologic results for COVID-19?
Resources:
https://news.mayocliniclabs.com/covid19/